View Press Releases
- 
                1upHealth Joins Early Adopter Program for NCQA Digital Content Services
 Oct 23, 2023
 
- 
                Proscia Achieves ISO 27001 Security CertificationCompliance with global information security management standard strengthens customer trust Oct 23, 2023
 
- 
                Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
 Oct 23, 2023
 
- 
                Creative Biostructure Announces Comprehensive Exosome Analysis Services
 Oct 23, 2023
 
- 
                Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach
 Oct 23, 2023
 
- 
                CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development
 Oct 23, 2023
 
- 
                Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies
 Oct 22, 2023
 
- 
                Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use
 Oct 23, 2023
 
- 
                Optibrium introduces cloud-based version of StarDrop drug discovery platformOptibrium introduces a cloud-based version of StarDrop, its drug discovery platform. Oct 22, 2023
 
- 
                Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
 Oct 8, 2023
 
- 
                Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
 Oct 22, 2023
 
- 
                Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech IndustryCreative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services. Oct 22, 2023
 
- 
                Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront
 Oct 18, 2023
 
- 
                Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney DiseasesAndelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic renal diseases that are currently poorly addressed. Oct 19, 2023
 
- 
                CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules
 Oct 18, 2023
 
- 
                Magritek opens up benchtop NMR to new reaction monitoring applications
 Oct 18, 2023
 
- 
                Cresset Targets International Growth with Innovate UK Scaleup ProgrammeDrug discovery specialists Cresset have joined Innovate UK’s Scaleup Programme for businesses with high growth potential Oct 17, 2023
 
- 
                New £30m Initiative to Address Global Threat by Accelerating the Pace of Antimicrobial InnovationPioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050 Oct 18, 2023
 
- 
                CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights
 Oct 10, 2023
 
- 
                CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
 Oct 18, 2023
 







